If you have any questions about clinical research at East Florida Eye Institute, or are interested in participating in a clinical trial, please contact us using this form

You may also submit your contact information and diagnosis if you would like to be contacted for a future clinical trial.




Geographic Atrophy secondary to AMD

a trial is available for anyone over the age of 50 to asses efficacy and safety of intravitreous administration of zimura for geographic atrophy. total study duration is 18 months


Ptosis

TWO TRIALS ARE AVaILABLE for adults who have been diagnosed with acquired blepharoptosis (ptosis).  
The purpose of THE FIRST study is to assess the efficacy and safety of a drug versus A placebo. THE dosing period OF THIS STUDY is 6 weeks. Total study duration is 8 weeks.  
The purpose of thE SECOND study is to access the EFFICACY AND safety of RVL-1201 versus A placebo over an extended dosing period of 12 weeks.  Total duration of study is 84 days.

Wet AMD

a trial is available for anyone over the age of 50 that has subfoveal cnv lesions secondary to amd. the purpose of this study is to evaluate the safety and efficacy of conbercept ivt compared to aflibercept in patients with wet amd. total study duration is 96 weeks 

Name *
Name



AdenoVitral and Bacterial Conjunctivitis

A trial is available for anyone with conjunctivitis. The purpose of this study is to treat conjunctivitis with Iodine and Dexamethasone ophthalmic suspension. Total study duration is 13 days

Post- Cataract Surgery

 A trial is available for adults who will be having cataract surgery at east florida eye institute. The purpose of this study is to assess the efficacy and safety of ISV-305 in patients with pain and inflammation post-cataract surgery.  Total study duration is 29 days.

Retinal Vein Occlusion

a trial is available for anyone over the age of 18 with rvo to demonstrate that sc cls-ta in conjunction with ivt aflibercept is superior to ivt aflibercept alone. total study duration is 48 weeks

Diabetic Macular Edema

A trial is available for adults who have Visual Impairment due to Diabetic Macular edema.  The purpose of this STUDY is to assess the efficacy and Safety of Brolucizumab versus Aflibercept.  Total duration 100 weeks.

Glaucoma Clinical Trial

A trial is available for anyone over the age of 18 with OAG or OHT. The purpose of this study is to control glaucoma by injecting sustained release Bimatoprost into the anterior chamber about every 4 months compared to Selective Laser Trabeculoplasty, or SLT. Total study duration is 1 year


Studies on the horizon:

biosimilar medication for amd • mebomian gland • biosimilar medication for dme


Special thanks to those who have participated in prior studies.

For those of you who have recently participated, thank you for helping us with recent approvals of:

eylea for wet macular degeneration and crvo • lucentis and OZURDEX for diabetic macular edema • omidria for cataract surgery • zioptan and simbrinza for glaucoma